Description
Tesamorelin
Stimulates the release of endogenous growth hormone, supports increased IGF-1, and is commonly referenced in visceral-fat reduction protocols.
Product Overview
- Format: Lyophilized vial
- Strength: 10 mg per vial
- Injection type: Subcutaneous
- Protocol: 5 days on / 2 days off
Dosing Guide
Amount in vial: 10 mg
BAC water: 1 mL
Amount per unit: 0.1 mg
Typical Dose
1 mg to 2 mg
10 to 20 units
Notes
Subcutaneous injection. Commonly referenced as taken before bedtime.
Disclaimer
This product is intended for research and informational purposes only.
Reviews
There are no reviews yet.